U.S. Senate Proposes Freeze on Trump Administration's Grant Rule Amidst Biomedical Research Concerns
The U.S. Senate has introduced a bipartisan provision to temporarily halt a rule proposed by the Trump Administration that would allow federal agencies to cancel grants without cause. This rule, put forward by the White House Office of Management and Budget, has faced criticism from biomedical researchers and business groups for potentially undermining scientific research and conflicting with Congress's control over federal funding. The Senate's provision aims to freeze this rule until December 11, providing a temporary reprieve as part of ongoing appropriations discussions. However, this provision is not yet law, as it lacks a counterpart in the House-passed bill, and both chambers are currently in recess.